Healthcare provider profile · identity verified

Moses I Park, M.D.

Internal Medicine · REDLANDS, CA · NPI 1528079639

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	801	234
Amlodipine Besylate	Amlodipine Besylate	372	108
Lisinopril	Lisinopril	365	103
Levothyroxine Sodium	Levothyroxine Sodium	249	85
Gabapentin	Gabapentin	233	64
Metformin Hcl	Metformin Hcl	230	70
Metoprolol Succinate	Metoprolol Succinate	225	66
Losartan Potassium	Losartan Potassium	211	70
Pantoprazole Sodium	Pantoprazole Sodium	187	51
Tamsulosin Hcl	Tamsulosin Hcl	181	56
Eliquis	Apixaban	168	40
Simvastatin	Simvastatin	168	43
Omeprazole	Omeprazole	165	44
Hydrochlorothiazide	Hydrochlorothiazide	162	46
Escitalopram Oxalate	Escitalopram Oxalate	127	31
Clopidogrel	Clopidogrel Bisulfate	126	36
Naproxen	Naproxen	126	37
Atenolol	Atenolol	116	26
Ibuprofen	Ibuprofen	110	38
Lovastatin	Lovastatin	108	32
Albuterol Sulfate Hfa	Albuterol Sulfate	103	47
Furosemide	Furosemide	103	35
Ozempic	Semaglutide	102	16
Famotidine	Famotidine	101	38
Metoprolol Tartrate	Metoprolol Tartrate	98	34
Duloxetine Hcl	Duloxetine Hcl	85	24
Benazepril Hcl	Benazepril Hcl	84	23
Alendronate Sodium	Alendronate Sodium	79	22
Trazodone Hcl	Trazodone Hcl	76	23
Azelastine Hcl	Azelastine Hcl	75	29
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	75	19
Glipizide Er	Glipizide	74	18
Carvedilol	Carvedilol	71	21
Trulicity	Dulaglutide	70	15
Rosuvastatin Calcium	Rosuvastatin Calcium	69	29
Xarelto	Rivaroxaban	69	14
Allopurinol	Allopurinol	66	18
Celecoxib	Celecoxib	65	13
Sildenafil Citrate	Sildenafil Citrate	65	12
Fluticasone Propionate	Fluticasone Propionate	59	21
Finasteride	Finasteride	57	17
Jardiance	Empagliflozin	54	11
Ezetimibe	Ezetimibe	51	14
Glipizide	Glipizide	50	17
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	48	suppressed
Metformin Hcl Er	Metformin Hcl	44	20
Synthroid	Levothyroxine Sodium	42	13
Montelukast Sodium	Montelukast Sodium	41	14
Potassium Chloride	Potassium Chloride	41	15
Spironolactone	Spironolactone	41	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	41	13
Meloxicam	Meloxicam	39	12
Valsartan	Valsartan	39	11
Terazosin Hcl	Terazosin Hcl	38	suppressed
Januvia	Sitagliptin Phosphate	37	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	35	12
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	32	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	31	11
Triamcinolone Acetonide	Triamcinolone Acetonide	31	15
Ramipril	Ramipril	29	suppressed
Ciclopirox	Ciclopirox	28	suppressed
Hydralazine Hcl	Hydralazine Hcl	28	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Levetiracetam	Levetiracetam	25	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	25	suppressed
Prednisone	Prednisone	25	18
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	21
Citalopram Hbr	Citalopram Hydrobromide	24	suppressed
Clonidine Hcl	Clonidine Hcl	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Methylprednisolone	Methylprednisolone	24	22
Propranolol Hcl	Propranolol Hcl	24	suppressed
Bupropion Hcl Sr	Bupropion Hcl	23	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Farxiga	Dapagliflozin Propanediol	23	suppressed
Sertraline Hcl	Sertraline Hcl	23	suppressed
Sucralfate	Sucralfate	23	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Lorazepam	Lorazepam	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Methocarbamol	Methocarbamol	19	suppressed
Klor-Con 10	Potassium Chloride	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	13
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Glimepiride	Glimepiride	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	suppressed
Memantine Hcl	Memantine Hcl	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	14	suppressed
Pravastatin Sodium	Pravastatin Sodium	14	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Trospium Chloride	Trospium Chloride	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Dulera	Mometasone/Formoterol	11	suppressed
Felodipine Er	Felodipine	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error